JSE gains as investors focus on vaccine rollouts and US stimulus deal

The JSE was firmer on Thursday, with its global peers mixed as investors pin their hope on Covid-19 vaccine rollouts, while investor focus also remains on the US stimulus deal.

Now that Britain has beaten the rest of the world in approving a German-US Covid vaccine candidate, the US looks to be next in line, with the US Food and Drug Administration (FDA) decision on the shot expected in mid-December. ..